» Articles » PMID: 10872471

The 26S Proteasome: a Molecular Machine Designed for Controlled Proteolysis

Overview
Publisher Annual Reviews
Specialty Biochemistry
Date 2000 Jun 29
PMID 10872471
Citations 568
Authors
Affiliations
Soon will be listed here.
Abstract

In eukaryotic cells, most proteins in the cytosol and nucleus are degraded via the ubiquitin-proteasome pathway. The 26S proteasome is a 2.5-MDa molecular machine built from approximately 31 different subunits, which catalyzes protein degradation. It contains a barrel-shaped proteolytic core complex (the 20S proteasome), capped at one or both ends by 19S regulatory complexes, which recognize ubiquitinated proteins. The regulatory complexes are also implicated in unfolding and translocation of ubiquitinated targets into the interior of the 20S complex, where they are degraded to oligopeptides. Structure, assembly and enzymatic mechanism of the 20S complex have been elucidated, but the functional organization of the 19S complex is less well understood. Most subunits of the 19S complex have been identified, however, specific functions have been assigned to only a few. A low-resolution structure of the 26S proteasome has been obtained by electron microscopy, but the precise arrangement of subunits in the 19S complex is unclear.

Citing Articles

Recent Advances in the Development of Immunoproteasome Inhibitors as Anti-Cancer Agents: The Past 5 Years.

Mancuso F, Di Chio C, Di Matteo F, Smaldone G, Iraci N, Giofre S Molecules. 2025; 30(3).

PMID: 39942858 PMC: 11819894. DOI: 10.3390/molecules30030755.


REV7: a small but mighty regulator of genome maintenance and cancer development.

Maggs L, McVey M Front Oncol. 2025; 14:1516165.

PMID: 39839778 PMC: 11747621. DOI: 10.3389/fonc.2024.1516165.


Activation of the 26S Proteasome to Reduce Proteotoxic Stress and Improve the Efficacy of PROTACs.

Sedlacek J ACS Pharmacol Transl Sci. 2025; 8(1):21-35.

PMID: 39816802 PMC: 11729432. DOI: 10.1021/acsptsci.4c00408.


Molecular basis for the stepwise and faithful maturation of the 20 proteasome.

Han Y, Han Q, Tang Q, Zhang Y, Liu K Sci Adv. 2025; 11(2):eadr7943.

PMID: 39792683 PMC: 11721566. DOI: 10.1126/sciadv.adr7943.


Inhibition of proteolytic and ATPase activities of the proteasome by the BTK inhibitor CGI-1746.

Akintola O, Patterson M, Smith J, DeMartino G, Mitra A, Kisselev A iScience. 2025; 27(11):110961.

PMID: 39759071 PMC: 11700655. DOI: 10.1016/j.isci.2024.110961.